Vimarsana
Biggest News Aggregation in the World

Tim Aitman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Aitman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Aitman Today - Breaking & Trending Today

Cancer testing technology that could 'transform' process handed millions - Vimarsana News

Cancer testing technology that could 'transform' process handed millions

A SCOTTISH medical technology company has announced £2.1 million additional seed financing – in an oversubscribed funding round – to complete…

BIOCAPTIVA announces oversubscribed £2.1 million additional seed financing to complete first in human trial with the BioCaptis - Vimarsana News

BIOCAPTIVA announces oversubscribed £2.1 million additional seed financing to complete first in human trial with the BioCaptis

/PRNewswire/ -- BIOCAPTIVA Ltd ("BIOCAPTIVA"), a company developing the BioCaptis – a revolutionary cell-free DNA (cfDNA) capture device designed to transform...

BioCaptiva Raises £2.1M in Seed Financing to Advance Liquid Biopsy Capture Device - Vimarsana News

BioCaptiva Raises £2.1M in Seed Financing to Advance Liquid Biopsy Capture Device

The funds will help the company complete its first study of the cell-free DNA capture device in humans and to plan future regulatory trials.

Edinburgh firm pioneering liquid biopsy tech welcomes seven-figure funding injection - Vimarsana News

Edinburgh firm pioneering liquid biopsy tech welcomes seven-figure funding injection

A University of Edinburgh spin-out that says it is pioneering technology to “transform” liquid biopsy testing in cancer-management has announced an oversubscribed £2.1 million additional seed funding round led by Archangels.

BIOCAPTIVA Ltd: BIOCAPTIVA announces oversubscribed £2.1 million additional seed financing to complete first in human trial with the BioCaptis - Vimarsana News

BIOCAPTIVA Ltd: BIOCAPTIVA announces oversubscribed £2.1 million additional seed financing to complete first in human trial with the BioCaptis

Deal financing led by existing investor, Archangels, with participation from Scottish Enterprise, Cancer Research Horizons and new investor Old College Capital, the University of Edinburgh's